Close

Array Biopharma (ARRY) Prices 18.4M Share Stock Offering for Proceeds of ~$115M

Go back to Array Biopharma (ARRY) Prices 18.4M Share Stock Offering for Proceeds of ~$115M

Array BioPharma Announces Pricing of Public Offering of Common Stock

September 27, 2016 9:23 PM EDT

BOULDER, Colo., Sept. 27, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) announced today the pricing of an underwritten public offering of 18,400,000 shares of its common stock at a public offering price of $6.25 per share. The gross proceeds from the sale of the shares, before underwriting discounts and commissions and offering expenses, are expected to be approximately $115 million. The offering is expected to close on or about October 3, 2016, subject to customary closing conditions. Array also granted the underwriters a 30-day option to purchase up to 2,760,000 additional shares of common... More

Array BioPharma Announces Proposed Public Offering of Common Stock

September 27, 2016 4:27 PM EDT

BOULDER, Colo., Sept. 27, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock. Array BioPharma also intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of shares of its common stock offered in the public offering. All of the shares in the offering are to be sold by Array... More